





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































SUMMARY PROTOCOL FORM (SPF) 
Office of Research – Research Ethics Unit – GM 900 – 514-848-2424 ext. 7481 – oor.ethics@concordia.ca – 
www.concordia.ca/offices/oor.html!
*
IMPORTANT INFORMATION FOR ALL RESEARCHERS 
Please take note of the following before completing this form:  
•! You must not conduct research involving human participants until you have received your Certification of Ethical 
Acceptability for Research Involving Human Subjects (Certificate). 
•! In order to obtain your Certificate, your study must receive approval from the appropriate committee: 
o! Faculty research, and student research involving greater than minimal risk is reviewed by the University 
Human Research Ethics Committee (UHREC).  
o! Minimal risk student research is reviewed by the College of Ethics Reviewers (CER; formerly the “Disciplinary 
College”), except as stated below. 
o! Minimal risk student research conducted exclusively for pedagogical purposes is reviewed at the departmental 
level. Do not use this form for such research. Please use the Abbreviated Summary Protocol Form, 
available on the Office of Research (OOR) website referenced above, and consult with your academic 
department for review procedures. 
•! Research funding will not be released until your Certificate has been issued, and any other required certification 
(e.g. biohazard, radiation safety) has been obtained. For information about your research funding, please consult: 
o! Faculty and staff: OOR  
o! Graduate students: School of Graduate Studies  
o! Undergraduate students: Financial Aid and Awards Office or the Faculty or Department  
•! Faculty members are encouraged to submit studies for ethics by uploading this form, as well as all supporting 
documentation, to ConRAD, which can be found in the MyConcordia portal. 
•! If necessary, faculty members may complete this form and submit it by e-mail to oor.ethics@concordia.ca along 
with all supporting documentation. Student researchers are asked to submit this form and all supporting 
documentation by e-mail, except for departmental review. Please note:  
o! Handwritten forms will not be accepted. 
o! Incomplete or omitted responses may result in delays. 
o! This form expands to accommodate your responses.  
•! Please allow the appropriate amount of time for your study to be reviewed: 
! ! !
^Y!
o! UHREC reviews greater than minimal risk research when it meets on the second Thursday of each month. 
You must submit your study 10 days before the meeting where it is to be reviewed. You will normally receive 
a response within one week of the meeting. Please confirm the deadline and date of the meeting with the staff 
of the Research Ethics Unit. 
o! CER reviews, and delegated reviews conducted by UHREC generequire 2 to 4 weeks. 
•! Research must comply with all applicable laws, regulations, and guidelines, including: 
o! The Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans 
o! The policies and guidelines of the funding/award agency  
o! The Official Policies of Concordia University, including the Policy for the Ethical Review of Research Involving Human 
Participants, VPRGS-3. 
•! The Certificate is valid for one year. In order to maintain your approval and renew your Certificate, please submit 
an Annual Report Form one month before the expiry date that appears on the Certificate. You must not conduct 
research under an expired Certificate.  
•! Please contact the Manager, Research Ethics at 514-848-2424 ext. 7481 if you need more information on the 
ethics review process or the ethical requirements that apply to your study. 
!
ADDITIONAL INFORMATION FOR STUDENT RESEARCHERS 
•! If your research is part of your faculty supervisor’s research, as approved, please have him or her inform the 
Research Ethics Unit via e-mail that you will be working on the study.  
•! If your research is an addition to your faculty supervisor’s study, please have him or her submit an amendment 
request, and any revised documents via e-mail. You must not begin your research until the amendment has been 
approved.  
 
INSTRUCTIONS FOR COMPLETING THIS FORM 
•! Please make sure that you are using the most recent version of the SPF by checking the OOR website. 
•! Please answer each question on the form; if you believe the question is not applicable, enter not applicable.  
•! Do not alter the questions on this form or delete any material. Where questions are followed by a checklist, 
please answer by checking the applicable boxes. 
•! The form can be signed and submitted as follows: 
o! Faculty research submitted on ConRAD will be considered as signed as per section 16.  
o! SPFs for faculty research submitted via the faculty member’s official Concordia e-mail address will also be 
considered as signed as per section 16. 
o! Both faculty and student researchers may submit a scanned pdf of the signature page by e-mail. In this case, 
the full SPF should also be submitted by e-mail in Word or pdf format (not scanned). 
o! If you do not have access to a scanner, the signature page may be submitted on paper to the OOR.  
!
ADDITIONAL DOCUMENTS 





Study Title:   The Psychosocial Effects of Having a Sibling with Autism Spectrum Disorder  
Principal Investigator:    Norah Jesseca Perlman  
 
Principal Investigator’s Status: 
 Concordia faculty or staff 
 Visiting scholar 
 Affiliate researcher 
 Postdoctoral fellow 
 PhD Student 
 Master’s student 
 Undergraduate student  
 Other (please specify):  
Type of submission: 
 New study 
 
Modification or an update of an approved study.  
Approved study number (e.g. 30001234):  
 
Where will the research be conducted? 
 Canada 
 Another jurisdiction:  
!
2. STUDY TEAM AND CONTACT INFORMATION* 
!
Role Name Institution† / 
Department / 
Address‡ 





















































































* If additional space is required, please submit a list of team members as a separate document. 
†For team members who are external to Concordia only. 
‡For individuals based at Concordia, please provide only the building and room number, e.g. GM-910.03.  
§For student research only. 
|For research conducted by PhD and Master’s students only. 
°Please include all co-investigators and research assistants. 
!
3. PROJECT AND FUNDING SOURCES 
 
Please list all sources of funds that will be used for the research. Please note that fellowships or scholarships are not 











h*0!,;;-+),6-%!! h*0!,;;-+),6-%!! h*0!,;;-+),6-%!! h*0!,;;-+),6-%!!
Notes: 
* Please provide the project title as it appears on the Notice of Award or equivalent documentation. 
† If you have applied for funding, and the decision is still pending, please enter “applied”. 
!
4. OTHER CERTIFICATION REQUIREMENTS 
 
Does the research involve any of the following (check all that apply):  
 Controlled goods or technology 
 Hazardous materials or explosives 
 Biohazardous materials 
 Human biological specimens 
 Radioisotopes, lasers, x-ray equipment or magnetic fields 
 Protected acts (requiring professional certification) 
 A medical intervention, healthcare intervention or invasive procedures 
Please submit any certification or authorization documents that may be relevant to ethics review for research involving human 
participants. 
 
5. LAY SUMMARY 
 
Please provide a brief description of the research in everyday language. The summary should make sense to a person 
with no discipline-specific training, and it should not use overly technical terms. Please do not submit your thesis 
proposal or grant application. 
!
! #$+'!:+M%>!:%0$*>!'09>(!'%%S'!0*!%M,:+3%!0$%!;'()$*-*4+),-C!'*)+,-C!,3>!6%$,2+*<,-!%//%)0'!
*/! $,2+34! ,! '+6-+34! 7+0$! ,90+':! /*<! 0$%+<! 0(;+),--(! >%2%-*;+34! '+6-+34J! O*<%*2%<C! ;*''+6-%!
,''*)+,0+*3'!6%07%%3!0$%'%!*90)*:%'!,3>!)*;+34!'0<,0%4+%'!7+--!6%!+32%'0+4,0%>J!!
! 5+6-+34'!,<%!,3!+30%4<,-!;,<0!*/!,3(!/,:+-(!,'!0$%(!;<*2+>%!%,)$!*0$%<!7+0$!0$%+<!/+<'0!'*)+,-!
%M;%<+%3)%'J! #$<*94$! 0$%+<! )*30+39*9'! +30%<,)0+*3'C! )$+-><%3! ;<,)0+)%! ,3>! '0<%340$%3! 0$%+<!
)*43+0+2%C!,//%)0+2%C!6%$,2+*<,-C!,3>!'*)+,-!'S+--'C!,--*7+34!0$%:!0*!%M;%<+%3)%!/<+%3>'$+;C!-*(,-0(C!
'9;;*<0C! ,3>! <+2,-<(! DX9$<:%'0%<C! "^^@b! =933C! @AALEJ! 1*7%2%<C! +3! ,! $*:%! 7$%<%! ,! )$+->! +'!
>+,43*'%>!7+0$!,90+':!0$%'%!+30%<,)0+*3'!:,(!3*0!6%!'*!)*::*3J!!




#7,<>U+SC!@A"LEJ!#$,0!6%+34!',+>C! 0$%!-+0%<,09<%!>%:*3'0<,0%'! 0$,0! 0(;+),--(!>%2%-*;+34!'+6-+34'!
$,2%! ,! ;*'+0+2%! +:;,)0! *3! 0$%+<! '+6-+34! 7+0$! ,90+':J! N*<! +3'0,3)%C! -%''! '%2%<%! )*::93+),0+*3!








! 8'! '9)$C! ;<%2+*9'! '09>+%'! $,2%! >*)9:%30%>! 0$%! ;*'+0+2%! ,3>! 3%4,0+2%! %M;%<+%3)%'! */!















! 8-0$*94$! 0$%<%!,<%!,!39:6%<!*/!;*''+6+-+0+%'!,'! 0*!7$(!'*:%!'+6-+34'!,>\9'0!6%00%<! 0$,3!
*0$%<!D%J4JC!;%<'*3,-+0(C!;,<%30+34!'0(-%'EC! 0$%!/*)9'!*/! 0$%!)9<<%30!'09>(!+'!*3!)$+-><%3K'!)*;+34!







>%2%-*;+34! '+6-+34lb! ,3>! DYE! 7$,0! ,';%)0'! */! 0$%+<! '+6-+34! <%-,0+*3'$+;! >*! 0(;+),--(! >%2%-*;+34!
'+6-+34'!%:;$,'+U%!:*'0!D+J%JC!;*'+0+2%C!3%4,0+2%El!!
! !
6. RISK LEVEL AND SCHOLARLY REVIEW 
 
As part of the research, will participants be exposed to risk that is greater than minimal? 
 
Minimal risk means that the probability and magnitude of the risks are greater than those to which participants would be 







Has this research received favorable review for scholarly merit?  
 
Scholarly review is not required for minimal risk research. 
 
For faculty research, funding from a granting agency such as CIHR, FQRSC, or CINQ is considered evidence of such review. 
Please provide the name of the agency.  
 
For student research, a successful defense of a thesis or dissertation proposal is considered evidence of such review. Please 
provide the date of your proposal defense.  
 
 Yes 
Funding agency or date 
of defense: Thursday, 
November 15, 2018 
!
 No  
 Not required 
 
If you answered no, please submit a Scholarly Review Form, available on the OOR website. For studies to be 




7.  RESEARCH PARTICIPANTS 
 
Will any of the participants be part of the following categories? 
 
 Minors (individuals under 18 years old) 
 Individuals with diminished mental capacity 
 Individuals with diminished physical capacity 
 Members of Canada’s First Nations, Inuit, or Métis peoples 
 Vulnerable individuals or groups (vulnerability may be caused by limited capacity, or limited 
access to social goods, such as rights, opportunities and power, and includes individuals or 
groups whose situation or circumstances make them vulnerable in the context of the 
research project, or those who live with relatively high levels of risk on a daily basis)   
 





b)! Please describe in detail how potential participants will be identified, and invited to participate. Please submit 








c)!  Please describe in detail what participants will be asked to do as part of the research, and any procedures 
they will be asked to undergo. Please submit any instruments to be used to gather data, for example questionnaires 
























d)! Do any of the research procedures require special training, such as medical procedures or conducting 
interviews on sensitive topics or with vulnerable populations? If so, please indicate who will conduct the procedures 






8. INFORMED CONSENT 
 
a)! Please explain how you will solicit informed consent from potential participants.  Please submit your 
written consent form. In certain circumstances, oral consent may be appropriate. If you intend to use an oral consent 
procedure, please submit a consent script containing the same elements as the template, and describe how consent 




Please note: written consent forms and oral consent scripts should follow the consent form template available on the OOR 









b)! Does your research involve individuals belonging to cultural traditions in which individualized consent 
may not be appropriate, or in which additional consent, such as group consent or consent from community leaders, 






Does your research involve any form of deception of participants?  If so, please describe the deception, explain why 
the deception is necessary, and explain how participants will be de-briefed at the end of their participation. If 
applicable, please submit a debriefing script. 
 
Please note that deception includes giving participants false information, withholding relevant information, and providing 




10. PARTICIPANT WITHDRAWAL 
 
a) Please explain how participants will be informed that they are free to discontinue at any time, and describe 





b)  Please explain what will happen to the information obtained from a participant if he or she withdraws. For 
example, will their information be destroyed or excluded from analysis if the participant requests it? Please describe 





11. RISKS AND BENEFITS 
 









b) Please identify any foreseeable risks to participants, including any physical or psychological discomfort, and 
risks to their relationships with others, or to their financial well-being. 
 





c) Please describe how the risks identified above will be minimized. For example, if individuals who are 
particularly susceptible to these risks will be excluded from participating, please describe how they will be identified. 
Furthermore, if there is a chance that researchers will discontinue participants’ involvement for their own well-being, 





d) Please describe how you will manage the situation if the risks described above are realized. For example, if 
referrals to appropriate resources are available, please provide a list. If there is a chance that participants will need 





12. REPORTABLE SITUATIONS AND INCIDENTAL FINDINGS 
 
a)! Is there a chance that the research might reveal a situation that would have to be reported to appropriate 
authorities, such as child abuse or an imminent threat of serious harm to specific individuals? If so, please describe 
the situation, and how it would be handled.  
 
Please note that legal requirements apply in such situations. It is the researcher’s responsibility to be familiar with the laws in 






b)!   Is there a chance that the research might reveal a material incidental finding? If so, please describe how it 
would be handled. 
 
Please note that a material incidental finding is an unanticipated discovery made in the course of research but that is outside 
the scope of the research, such as a previously undiagnosed medical or psychiatric condition that has significant welfare 






13. CONFIDENTIALITY, ACCESS, AND STORAGE 
 
a)! Please describe the path of your data from collection to storage to its eventual archiving or disposal, 
including details on short and long-term storage (format, duration, and location), measures taken to prevent 








b)  Please identify the access that the research team will have to participants’ identity: 
 
c)! Please describe what access research participants will have to study results, and any debriefing information 
that will be provided to participants post-participation. 
&,<0+)+;,0+34!/,:+-+%'!7+--!6%!'%30!,!'9::,<(!*/!0$%!*2%<,--!/+3>+34'!*3)%!0$%!'09>(!+'!)*:;-%0%J!!
 
 Anonymous The information provided never had identifiers associated with it, and the risk of identification of individuals is low, or very low. 
 Anonymous results, but identify who participated 
The information provided never had identifiers associated with 
it. The research team knows participants’ identity, but it would 
be impossible to link the information provided to link the 
participant’s identity. 
 Pseudonym 
Information provided will be linked to an individual, but that 
individual will only provide a fictitious name.  The research team 
will not know the real identity of the participant.  
 Coded 
Direct identifiers will be removed and replaced with a code on 
the information provided. Only specific individuals have access 
to the code, meaning that they can re-identify the participant if 
necessary.  
 Indirectly identified 
The information provided is not associated with direct 
indentifiers (such as the participant’s name), but it is associated 
with information that can reasonably be expected to identify an 
individual through a combination of indirect identifiers (such as 
place of residence, or unique personal characteristics). 
 Confidential The research team will know the participants’ real identity, but it will not be disclosed. 
 Disclosed The research team will know the participants’ real identity, and it will be revealed in accordance with their consent. 
 Participant Choice Participants will be able to choose which level of disclosure they wish for their real identity. 
 Other (please describe)  
! ! !
"AY!
d)   Would the revelation of participants’ identity be particularly sensitive, for example, because they belong to 
a stigmatized group? If so, please describe any special measures that you will take to respect the wishes of your 
participants regarding the disclosure of their identity. 
&,<0+)+;,30!+>%30+0+%'!7+--!3%2%<!6%!>+')-*'%>b!*3-(!0$%!<%'%,<)$%<!7+--!$,2%!,))%''J!!
 
e)  In some research traditions, such as action research, and research of a socio-political nature, there can be 
concerns about giving participant groups a “voice”.  This is especially the case with groups that have been oppressed 
or whose views have been suppressed in their cultural location. If these concerns are relevant for your participant 





14. MULTI-JURISDICTIONAL RESEARCH 
 
Does your research involve researchers affiliated with an institution other than Concordia? If so, please complete 
the following table, including the Concordia researcher’s role and activities to be conducted at Concordia. If 







Role in the research  
(e.g. principal investigator, 
co-investigator, 
collaborator) 
What research activities 









15. ADDITIONAL ISSUES 
 
Bearing in mind the ethical guidelines of your academic or professional association, please comment on any other 
ethical concerns which may arise in the conduct of this research. For example, are there responsibilities to 
participants beyond the purposes of this study? 
!
16. DECLARATION AND SIGNATURE  
 
Study Title: #$%!&'()$*'*)+,-!.//%)0'!*/!1,2+34!,!5+6-+34!7+0$!890+':!5;%)0<9:!=+'*<>%<J  
 
I hereby declare that this Summary Protocol Form accurately describes the research project or scholarly activity 
that I plan to conduct. I will submit a detailed modification request if I wish to make modifications to this research.  
 
I agree to conduct all activities conducted in relation to the research described in this form in compliance with all 
applicable laws, regulations, and guidelines, including: 
o! The Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans 
o! The policies and guidelines of the funding/award agency  
! ! !
"AB!




Principal Investigator Signature: ____ __________________________     
 
Date: ___November 20, 2018___________________________     
 
FACULTY SUPERVISOR STATEMENT (REQUIRED FOR STUDENT PRINCIPAL 
INVESTIGATORS):   
 
I have read and approved this project. I affirm that it has received the appropriate academic approval, and that the 
student investigator is aware of the applicable policies and procedures governing the ethical conduct of human 
participant research at Concordia University. I agree to provide all necessary supervision to the student. I allow 
release of my nominative information as required by these policies and procedures in relation to this project.  
 
Faculty Supervisor Signature: _____ ______________________________   
 















































































INFORMATION AND CONSENT FORM 
 
Study Title: 1,2+34!,!5+6-+34!7+0$!890+':!5;%)0<9:!=+'*<>%<J  
Researcher: R%''%),!&%<-:,3  
Researcher’s Contact Information: R%''%),J;%<-:,3}4:,+-J)*:  
Faculty Supervisor: =<J!h+3,!1*7%  
Faculty Supervisor’s Contact Information: nina.howe@concordia.ca 
Source of funding for the study: h*0!,;;-+),6-%J  
 
You are being invited to participate in the research study mentioned above. This form provides 
information about what participating would mean. Please read it carefully before deciding if you 
want to participate or not. If there is anything you do not understand, or if you want more 






























C. RISKS AND BENEFITS 
 
#$%<%! ,<%! 3*! /*<%'%%,6-%! <+'S'! +3! 0$+'! '09>(J! #$%<%! ,<%! 3*! >+<%)0! 6%3%/+0'! /*<! 0$%! +3>+2+>9,-'!






! ! #$%! +3/*<:,0+*3! 7%! 4,0$%<! 7+--! 6%! )*>%>C! 7$+)$! :%,3'! 0$,0! 0$%! ;,<0+)+;,30! 7+--! 6%!













+3/*<:,0+*3C! (*9! :9'0! 0%--! 0$%! <%'%,<)$%<! "! :*30$! ,/0%<! 0$%! +3+0+,-! :%%0+34J! ?3! 0$%! ),'%! */!
7+0$><,7,-C!,--!+3/*<:,0+*3!7+--!6%!>%'0<*(%>J!!
 
If participants are being offered compensation: 
 
! 8'!,!)*:;%3',0*<(!+3>%:3+0(!/*<!;,<0+)+;,0+34!+3!0$+'!<%'%,<)$C!,--!0$%!)$+-><%3!+3!0$%!$*:%!
7+--! <%)%+2%! ,3! ,4%W,;;<*;<+,0%! 4+/0J! #$%<%! ,<%! 3*! 3%4,0+2%! )*3'%Z9%3)%'! /*<! 3*0! ;,<0+)+;,0+34C!
'0*;;+34!+3!0$%!:+>>-%C!*<!,'S+34!9'!3*0!0*!9'%!(*9<!+3/*<:,0+*3J!!
 

































































































































































































































































































































































































































































































































































































































































































































"! ! M! ! N! ! O! ! Q! ! V! ! #!



































































































































































































































































































"8! ,!X23-!-.)&(!-4!54.B&-!)-8! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
#8! ,!()(!34<&-?)'B!;)G&!07->?!_Q!4.!
%;7:&(!7!B7<&!-4!54.B&-!)-8! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
E8! ,!3-7:&(!=:!<:3&;58!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
S8! ,!G&%-!L2)&-!7=42-!-?&!%.4=;&<8! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
T8! ,!-.)&(!-4!3&&!-?&!B44(!3)(&!45!-?)'B38! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
U8! ,!=;7<&(!<:3&;5!54.!>723)'B!-?&!
%.4=;&<8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
V8! ,!=;7<&(!34<&4'&!&;3&!54.!>723)'B!
-?&!%.4=;&<8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
W8! ,!-.)&(!-4!5)*!-?&!%.4=;&<!=:!-?)'G)'B!
45!7'30&.38!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
Y8! ,!-.)&(!-4!5)*!-?&!%.4=;&<!=:!(4)'B!
34<&-?)'B!4.!-7;G)'B!-4!34<&4'&8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
"Z8!,!:&;;&(M!3>.&7<&(M!4.!B4-!<7(8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
""8!,!-.)&(!-4!>7;<!<:3&;5!(40'8! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
"#8!,!0)3?&(!-?&!%.4=;&<!?7(!'&/&.!
?7%%&'&(8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
"E8!,!0)3?&(!,!>42;(!<7G&!-?)'B3!
()55&.&'-8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
"S8!,!-.)&(!-4!5&&;!=&--&.!=:!3%&'()'B!
-)<&!0)-?!4-?&.3!;)G&!57<);:M!
B.40'2%3M!4.!5.)&'(38!!
b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
"T8!,!()('@-!(4!7':-?)'B!=&>723&!-?&!
%.4=;&<!>42;('@-!=&!5)*&(8!! b&3!!!!!!!!P4! P4-!7-!7;;!!!!!!!!!!!!!!!$!;)--;&!!!!!!!!!!!!!!!$!;4-!
!
!
!
!
! ! !
"EZ!
$%%&'()*!c!
,'-&./)&0!12&3-)4'3!54.!+4>7;!C)=;)'B3!
#8! 97'!:42!-&;;!<&!7!;)--;&!7=42-!H3)=;)'B@3!'7<&IA!!
!! 97'!:42!-&;;!<&!7!5&0!4-?&.!-?)'B3A!
E8! ^?7-!(4&3!?&N3?&!;)G&A!D4!54.!52'A!!
!! ,3!-?&.&!7':-?)'B!&;3&A!
S8! ^?7-!(4&3!?&N3?&!'4-!;)G&A!!
!! ,3!-?&.&!7':-?)'B!&;3&A!
T8! ^?7-!7.&!34<&!-?)'B3!:42!5)'(!?7.(!7=42-!=&)'B!7!3)=;)'B!-4!H'7<&IA!
!! 97'!:42!-&;;!<&!7!;)--;&!<4.&A!
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